Low-dose Pimecrolimus, an FDA-approved Calcineurin Inhibitor, Sensitizes Drug-resistant Cancer Cells via Strong P-gp Inhibition.
Anticancer Res
; 43(3): 1103-1112, 2023 Mar.
Article
in En
| MEDLINE
| ID: mdl-36854528
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Tacrolimus
/
ATP Binding Cassette Transporter, Subfamily B, Member 1
/
Calcineurin Inhibitors
/
Neoplasms
Limits:
Humans
Language:
En
Journal:
Anticancer Res
Year:
2023
Document type:
Article